In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
Level 5 - mechanism / opinion, no new human data
Animal and bench research (in vivo mouse models).
PubMed 27984723 · doi:10.1016/j.cell.2016.11.052
What was done
Researchers evaluated the effect of partial cellular reprogramming via short-term cyclic in vivo expression of Oct4, Sox2, Klf4, and c-Myc (OSKM). The regimen was tested for its impact on lifespan and physiological aging markers in a progeroid mouse model, as well as on tissue repair following metabolic disease and muscle injury in older wild-type mice.
What was found
The abstract reports no numerical values, effect sizes, or sample sizes. It reports that cyclic OSKM expression ameliorated cellular and physiological hallmarks of aging, prolonged lifespan in premature-aging mice, and improved recovery from metabolic disease and muscle injury in aged wild-type mice.
Why it matters
This work provides proof-of-concept that transient in vivo epigenetic remodeling can counter physiological markers of mammalian aging without requiring full cellular dedifferentiation.
Limits
The abstract provides no quantitative metrics, confidence intervals, or sample sizes. Findings are limited to transgenic mouse models, and therapeutic viability, human translation, and potential oncogenic or teratoma risks of in vivo pluripotency factor induction cannot be evaluated from this text alone.
Cited by
- supports Juan Carlos Izpisua Belmonte conducted studies in progeria mice showing that partial cellular reprogramming rejuvenated certain organs and extended lifespan.